IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,639,710 | -4.0% | 17,684,816 | +14.1% | 0.18% | +1.1% |
| Q2 2023 | $292,387,206 | +362.7% | 15,499,788 | -5.8% | 0.18% | +333.3% |
| Q1 2023 | $63,192,990 | +305.2% | 16,450,081 | +422.6% | 0.04% | +281.8% |
| Q4 2022 | $15,596,246 | +148.5% | 3,147,576 | +20.1% | 0.01% | +120.0% |
| Q3 2022 | $6,277,271 | +532.2% | 2,620,984 | +1089.4% | 0.01% | +400.0% |
| Q2 2022 | $993,000 | -83.1% | 220,360 | -82.2% | 0.00% | -66.7% |
| Q1 2022 | $5,888,000 | +87.5% | 1,238,327 | +192.2% | 0.00% | +200.0% |
| Q4 2021 | $3,141,000 | +2704.5% | 423,863 | +2055.4% | 0.00% | – |
| Q3 2021 | $112,000 | – | 19,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |